Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the manufacturing and sale of Chinese and Western medicines primarily in China. The company provides functional cosmetics, such as eye care, eye daily necessities, facial and body cleaning, and care products; functional care products include infant paper, infant skin care, feminine products, etc.; functional foods, including moisturizing the intestines, promoting digestion, and nourishing the kidneys. It also offers foundation and dietary supplements; medical products comprising anorectal postoperative care, daily electronic auxiliary products, eye device care, disinfection and sterilization, etc. In addition, the company is involved in the development, production, and sale of pharmaceutical products; retail and wholesale of medical devices and drugs; provision of hospital medical and management service; and hospital operations. It sells its products through online stores. Mayinglong Pharmaceutical Group Co., Ltd., was founded in 1582 and is headquartered in Wuhan, China.
Metrics to compare | 600993 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600993PeersSector | |
---|---|---|---|---|
P/E Ratio | 23.7x | 32.9x | −0.5x | |
PEG Ratio | 1.31 | −0.17 | 0.00 | |
Price/Book | 3.0x | 3.3x | 2.6x | |
Price / LTM Sales | 3.4x | 5.5x | 3.3x | |
Upside (Analyst Target) | 21.9% | 12.6% | 43.5% | |
Fair Value Upside | Unlock | 3.5% | 6.3% | Unlock |